Insights from analysts' 12-month price targets are revealed, presenting an average target of $51.3, a high estimate of $61.00, and a low estimate of $31.00. A 14.64% drop is evident in the current ...

In a report released today, Chris Quintero from Morgan Stanley maintained a Buy rating on Vertex (VERX – Research Report), with a price target ...

A life sciences company is setting up shop in Durham to take advantage of the area's robust talent pool and thriving biotech ...

Zacks Research has upped the financial bar for Vertex Pharmaceuticals, boosting its 2026 earnings forecast from $16.18 to $16 ...

Meet the author: Dr. Phil Plait is an astronomer, author, and science communicator with a PhD in astronomy at the University ...

COMMENT: Almost overnight, the affable ‘Game of Thrones’ star seems to have become the most in-demand actor in Hollywood.

Google has announced it is adding its text-to-music model Lyria to Vertex AI. Vertex AI is now the only generative AI ...

AskBio Inc. (AskBio), a wholly owned and independently operated subsidiary of Bayer AG, announced today that its Board of Directors has elected Independent Director Laura Sepp-Lorenzino, PhD, to the ...

But there are smarter ways to go about it. You could also wiggle the needle back and forth while turning it, in a way that forms a triangle with curved edges instead. “It’s just a problem about how ...

This roundup is meant to highlight some of the most notable funding rounds of the month and is not intended to be ...

Despite a $400 million impairment charge, analysts say the removal of a drug-device combo from its portfolio is not a huge loss for Vertex given that the company has a more advanced type 1 diabetes ...

We recently published a list of 20 Most Expensive Stocks Insiders Are Dumping In March. In this article, we are going to take a look at where Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) stands ...